Clinical Trials
67 trialsNatural History Study of GATA2 Deficiency and Related Disorders
National Institutes of Health Clinical Center (CC)
ENKLA-M
Nantes University Hospital
CHIS
Assistance Publique - Hôpitaux de Paris
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Children's Hospital Medical Center, Cincinnati
NICHE
Institute of Hematology & Blood Diseases Hospital, China
Activity Levels in Bone Marrow Transplant Patients
University of Iowa
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
UNC Lineberger Comprehensive Cancer Center
REBOUND
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
HALO-SCT
Affiliated Hospital of Qinghai University
Expression Pattern and Possible Clinical Significance of CD81 In Myeloid Leukemia
Assiut University
EpiC
University Hospital, Bordeaux
Registry of Older Patients With Cancer
UNC Lineberger Comprehensive Cancer Center
Protocol For Genomically Profiling, Collecting, Archiving And Distributing Blood And Bone Marrow Specimens From Children And Young Adults With Hematologic Malignancy
Dana-Farber Cancer Institute
CARCML
Hikma Pharmaceuticals LLC
Blood Samples to Identify Biomarkers of Busulfan
Fred Hutchinson Cancer Center
Understanding What Matters Most to Patients: Establishing the Validity of a Best-Worst Scaling Survey
UNC Lineberger Comprehensive Cancer Center
Myeloproliferative Neoplasms (MPNs) Patient Registry
University Health Network, Toronto
HemaTMA
Tampere University Hospital
Chronic Myeloid Leukemia (CML) Real-Life Database
University Hospital, Clermont-Ferrand
OMNI
Takeda
MPL - NPM
Centre Hospitalier Universitaire de Nīmes
Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial
Alliance for Clinical Trials in Oncology
Blood Samples to Identify Biomarkers in Haploidentical Graft Recipients
Fred Hutchinson Cancer Center
Interventional Validation of an MDS-Specific Measure of Quality of Life: Assessing the Responsiveness of the Quality of Life in Myelodysplasia Scale (QUALMS-1) to Different Hypomethylating Agent Regimens for Low and Intermediate Risk Disease
M.D. Anderson Cancer Center
A Study to Analyze the Occurrence of Transformation From Myelodysplastic Syndrome to Acute Myeloid Leukemia in Patients With Myelodysplastic Syndrome Who Received Revlimid® 5 mg Capsules and Who Are Continuing or no Longer Continuing Revlimid Treatment
Celgene
Collecting and Storing Blood Samples From Patients With Cancer
Rutgers, The State University of New Jersey
Effectiveness and Safety Study of Generic Imatinib in Chronic Myeloid Leukemia Patients in Egypt
Hikma Pharmaceuticals LLC
Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell Transplant
Memorial Sloan Kettering Cancer Center
Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation
Memorial Sloan Kettering Cancer Center
Health Outcomes of Recently Diagnosed Myelodysplastic Syndrome (MDS)/Chronic Myelomonocytic Leukemia (CMML) Patients Depending on Treatment Strategy (Wait and See, Support, Active Treatment)
Celgene
Molecular Epidemiology of Therapy-related Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS)
M.D. Anderson Cancer Center
Symptom Burden in Chronic Myeloid Leukemia (CML)
M.D. Anderson Cancer Center
PREDICARE
LEO Pharma
T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
Vanderbilt-Ingram Cancer Center
OCEAN
Celgene
Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation
National Institutes of Health Clinical Center (CC)
Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant
The Cleveland Clinic
Evaluating Cell Damage in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, or Fanconi Anemia; in Patients Who Were Exposed to Alkylating Agents; and in Healthy Volunteers
OHSU Knight Cancer Institute
Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant
City of Hope Medical Center
Collection of Blood and Bone Marrow Samples From Select Patients With CML to Measure Minimal Residual Disease
National Institutes of Health Clinical Center (CC)
Blood Samples From Patients on a Clinical Trial to CINV During HSCT
OHSU Knight Cancer Institute
Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone
Vanderbilt University Medical Center
Comparative Evaluation of Results of Allogeneic Hematopoietic Stem Cells Versus Ponatinib in CML Patients Carrying a Mutation T315I
Hospices Civils de Lyon
Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML)
Stanford University
B-Receptor Signaling in Cardiomyopathy
Stanford University
Study of Natural Killer Cells in Bone Marrow and Blood Samples From Patients With and Without Hematologic Cancer
Case Comprehensive Cancer Center
Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers
Rutgers, The State University of New Jersey
Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity
PX Biosolutions
S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
SWOG Cancer Research Network